Diagnostic value of P63 in differentiating normal gestation from molar pregnancy

Background: Considering the limitations of current pathologic methods in distinguishing two subtypes of hydatidiform mole and non-molar pregnancy, the utility of immunohistochemical markers in this regards and the importance of differentiating of mentioned pathologic patterns, in this study the expr...

Full description

Bibliographic Details
Main Authors: Mitra Heidarpour, Marzieh Khanahmadi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=6;spage=462;epage=466;aulast=Heidarpour
_version_ 1811240394419077120
author Mitra Heidarpour
Marzieh Khanahmadi
author_facet Mitra Heidarpour
Marzieh Khanahmadi
author_sort Mitra Heidarpour
collection DOAJ
description Background: Considering the limitations of current pathologic methods in distinguishing two subtypes of hydatidiform mole and non-molar pregnancy, the utility of immunohistochemical markers in this regards and the importance of differentiating of mentioned pathologic patterns, in this study the expression of P63 in patients with complete hydatidiform mole (CHM), partial hydatidiform mole (PHM) and non-molar pregnancy was determined. Materials and Methods: In this study, formalin-fixed and paraffin-embedded tissues of 61 patients with definitive pathologic diagnosis of CHM, PHM and non-molar pregnancy retrieved. Diagnoses were based on the study of hematoxylin and eosin stained slides. Sections from all samples were stained for P63 marker using immunohistochemistry method. The nuclear immune reactivity of P63 marker in the three pathologic groups was determined by two pathologists. Results: P63 immune-staining was used to evaluate 20, 26 and 15 non-molar pregnancy, CHM and PHM cases, respectively. Mean ± SD of P63 nuclear immune-staining in molar pregnancy (CHM and PHM) and non-molar pregnancy were 32.4 ± 17.4 and 18.9 ± 17.2, respectively ( P = 0.006). The means were significantly different between non-molar pregnancy and PHM ( P < 0.000), CHM and PHM ( P = 0.02) and non-molar pregnancy and CHM ( P = 0.04). Conclusion: Considering the findings of the current study, though the nuclear immunoreactivity of P63 was higher in molar than non-molar pregnancy and in PHM than CHM, but using this marker alone is not suitable as a diagnostic test due to its low sensitivity and specificity. It could be used as adjuvant test in conflict cases. It is recommended to evaluate the role of other immunohistochemical markers like Ki-67 in this regard.
first_indexed 2024-04-12T13:19:23Z
format Article
id doaj.art-3958f29ef4e94a84a012d07e52a936c2
institution Directory Open Access Journal
issn 1735-1995
1735-7136
language English
last_indexed 2024-04-12T13:19:23Z
publishDate 2013-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Research in Medical Sciences
spelling doaj.art-3958f29ef4e94a84a012d07e52a936c22022-12-22T03:31:34ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362013-01-01186462466Diagnostic value of P63 in differentiating normal gestation from molar pregnancyMitra HeidarpourMarzieh KhanahmadiBackground: Considering the limitations of current pathologic methods in distinguishing two subtypes of hydatidiform mole and non-molar pregnancy, the utility of immunohistochemical markers in this regards and the importance of differentiating of mentioned pathologic patterns, in this study the expression of P63 in patients with complete hydatidiform mole (CHM), partial hydatidiform mole (PHM) and non-molar pregnancy was determined. Materials and Methods: In this study, formalin-fixed and paraffin-embedded tissues of 61 patients with definitive pathologic diagnosis of CHM, PHM and non-molar pregnancy retrieved. Diagnoses were based on the study of hematoxylin and eosin stained slides. Sections from all samples were stained for P63 marker using immunohistochemistry method. The nuclear immune reactivity of P63 marker in the three pathologic groups was determined by two pathologists. Results: P63 immune-staining was used to evaluate 20, 26 and 15 non-molar pregnancy, CHM and PHM cases, respectively. Mean ± SD of P63 nuclear immune-staining in molar pregnancy (CHM and PHM) and non-molar pregnancy were 32.4 ± 17.4 and 18.9 ± 17.2, respectively ( P = 0.006). The means were significantly different between non-molar pregnancy and PHM ( P < 0.000), CHM and PHM ( P = 0.02) and non-molar pregnancy and CHM ( P = 0.04). Conclusion: Considering the findings of the current study, though the nuclear immunoreactivity of P63 was higher in molar than non-molar pregnancy and in PHM than CHM, but using this marker alone is not suitable as a diagnostic test due to its low sensitivity and specificity. It could be used as adjuvant test in conflict cases. It is recommended to evaluate the role of other immunohistochemical markers like Ki-67 in this regard.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=6;spage=462;epage=466;aulast=HeidarpourComplete hydatidiform moleP63partial hydatidiform molepregnancytrophoblastic disease
spellingShingle Mitra Heidarpour
Marzieh Khanahmadi
Diagnostic value of P63 in differentiating normal gestation from molar pregnancy
Journal of Research in Medical Sciences
Complete hydatidiform mole
P63
partial hydatidiform mole
pregnancy
trophoblastic disease
title Diagnostic value of P63 in differentiating normal gestation from molar pregnancy
title_full Diagnostic value of P63 in differentiating normal gestation from molar pregnancy
title_fullStr Diagnostic value of P63 in differentiating normal gestation from molar pregnancy
title_full_unstemmed Diagnostic value of P63 in differentiating normal gestation from molar pregnancy
title_short Diagnostic value of P63 in differentiating normal gestation from molar pregnancy
title_sort diagnostic value of p63 in differentiating normal gestation from molar pregnancy
topic Complete hydatidiform mole
P63
partial hydatidiform mole
pregnancy
trophoblastic disease
url http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=6;spage=462;epage=466;aulast=Heidarpour
work_keys_str_mv AT mitraheidarpour diagnosticvalueofp63indifferentiatingnormalgestationfrommolarpregnancy
AT marziehkhanahmadi diagnosticvalueofp63indifferentiatingnormalgestationfrommolarpregnancy